SACCARDI, RICCARDO
 Distribuzione geografica
Continente #
NA - Nord America 2.964
EU - Europa 1.983
AS - Asia 1.578
SA - Sud America 190
AF - Africa 53
OC - Oceania 17
Totale 6.785
Nazione #
US - Stati Uniti d'America 2.931
RU - Federazione Russa 1.002
SG - Singapore 474
CN - Cina 418
IT - Italia 236
HK - Hong Kong 233
IE - Irlanda 219
KR - Corea 164
SE - Svezia 160
BR - Brasile 157
PL - Polonia 96
IN - India 81
VN - Vietnam 73
DE - Germania 66
FI - Finlandia 48
JO - Giordania 42
GB - Regno Unito 37
CH - Svizzera 36
FR - Francia 28
IR - Iran 22
ID - Indonesia 17
AU - Australia 16
CA - Canada 16
ES - Italia 15
EG - Egitto 14
CI - Costa d'Avorio 13
AR - Argentina 12
MX - Messico 12
NL - Olanda 12
MA - Marocco 11
BD - Bangladesh 10
EC - Ecuador 10
TR - Turchia 10
UA - Ucraina 8
CO - Colombia 7
ZA - Sudafrica 6
BE - Belgio 4
PK - Pakistan 4
AT - Austria 3
AZ - Azerbaigian 3
IQ - Iraq 3
JP - Giappone 3
KE - Kenya 3
PH - Filippine 3
UZ - Uzbekistan 3
BJ - Benin 2
CL - Cile 2
DZ - Algeria 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LI - Liechtenstein 2
LT - Lituania 2
MY - Malesia 2
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
CR - Costa Rica 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GE - Georgia 1
HN - Honduras 1
IL - Israele 1
IS - Islanda 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
MZ - Mozambico 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
PT - Portogallo 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
SA - Arabia Saudita 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SY - Repubblica araba siriana 1
UY - Uruguay 1
Totale 6.785
Città #
Santa Clara 883
Singapore 330
Ashburn 321
Dublin 219
Hong Kong 202
Fairfield 191
Chandler 184
Seoul 163
Hefei 110
Beijing 106
Warsaw 94
Woodbridge 84
Altamura 71
Lawrence 71
Cambridge 69
Seattle 67
Wilmington 67
Houston 57
Los Angeles 53
Florence 52
Mumbai 52
Ann Arbor 47
Buffalo 46
Kent 46
Munich 43
Princeton 42
Boston 40
Dallas 37
Bern 35
New York 31
Milan 30
Ho Chi Minh City 27
Moscow 27
Clifton 23
Turku 23
Dearborn 19
São Paulo 17
Hanoi 16
Paris 16
Shanghai 16
Melbourne 15
The Dalles 15
Medford 14
Abidjan 13
Jakarta 13
San Diego 12
Frankfurt am Main 11
Redondo Beach 11
Helsinki 10
Boardman 9
Cairo 9
Casablanca 9
Falls Church 9
Guangzhou 9
Barcelona 8
Yubileyny 8
Bengaluru 7
Lappeenranta 7
Norwalk 7
Montreal 6
Rome 6
Curitiba 5
Jacksonville 5
London 5
Manchester 5
Pune 5
Rio de Janeiro 5
Tehran 5
Andover 4
Belo Horizonte 4
Brussels 4
Chennai 4
Denver 4
Dong Ket 4
Haiphong 4
Orem 4
Ottawa 4
Porto Alegre 4
Santo André 4
Tanta 4
Toronto 4
West Jordan 4
Amsterdam 3
Ankara 3
Baku 3
Biên Hòa 3
Da Nang 3
Dhaka 3
Fuzhou 3
Hangzhou 3
Hillsboro 3
Jinan 3
Johannesburg 3
Kunming 3
Livorno 3
Medellín 3
Mexico City 3
Pelotas 3
Poplar 3
Quito 3
Totale 4.380
Nome #
A non-traditional approach to cryopreservation by ultra-rapid cooling for human mesenchymal stem cells 227
Therapeutic efficacy of autologous non-mobilized enriched circulating endothelial progenitors in patients with critical limb ischemia ― The scelta trial 219
Bio-Engineered Mesenchymal Stromal Cell (MSCs) Grafts for Skin Repair/Regeneration. Preclinical Aspects 197
The TCR Repertoire Reconstitution in Multiple Sclerosis: Comparing One-Shot and Continuous Immunosuppressive Therapies 189
Effect of the COVID-19 pandemic on disease activity in multiple sclerosis patients treated with hematopoietic stem cell transplantation 175
Autologous Stem Cell Transplantation International Multiple Sclerosis (ASTIMS) trial: a randomised, phase II, controlled, multicentre trial 168
Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: The Italian multi-centre experience 166
Autologous stem cell transplantation is safe in selected elderly multiple myeloma patients 165
Immunohistochemistry analysis of bone marrow biopsies in multiple sclerosis patients undergoing autologous haematopoietic stem cells transplantation 165
Neuropsychological assessment in aggressive multiple sclerosis treated with stem cell transplantation 158
Evidence for reduced angiogenesis in bone marrow in SSc: immunohistochemistry and multiparametric computerized imaging analysis. 157
Spinal cord size as promising biomarker of disability outcomes after hematopoietic stem cell transplantation in multiple sclerosis 154
Leptomeningeal enhancement in multiple sclerosis: a focus on patients treated with hematopoietic stem cell transplantation 153
MSCs seeded on bioengineered scaffolds improve skin wound healing in rats. 151
5-methyltetrahydrofolate (mTHF) induces monocytes differentiation in HL60 cells 149
Long-term SARS-CoV-2 Asymptomatic Carriage in an Immunocompromised Host: Clinical, Immunological, and Virological Implications 149
Impact of autologous haematopoietic stem cell transplantation on disability and brain atrophy in secondary progressive multiple sclerosis 140
Human mesenchymal stromal cells preserve their stem features better when cultured in the Dulbecco's modified Eagle medium. 139
Intermediate-Intensity Autologous Hematopoietic Stem Cell Transplantation Reduces Serum Neurofilament Light Chains and Brain Atrophy in Aggressive Multiple Sclerosis. 138
Efficacy of autologous hematopoietic stem cell transplantation in secondary progressive Multiple sclerosis 137
Intravesical application of platelet-rich plasma in patients with persistent haemorrhagic cystitis after hematopoietic stem cell transplantation: a single-centre preliminary experience 133
The effects of Exendin-4 on bone marrow-derived mesenchymal cells. 131
AIDS patient with severe T cell depletion achieved control but not clearance of SARS-CoV-2 infection 131
Cost and effectiveness of autologous haematopoietic stem cell transplantation and high-efficacy disease-modifying therapies in relapsing–remitting multiple sclerosis 129
Reconstitution of natural or vaccination-driven immunity after aHSCT in multiple sclerosis 128
CMV AND EBV REACTIVATION AFTER AUTOLOGOUS HAEMOPOIETIC STEM CELL TRANSPLANTATION WITH BEAM CONDITIONING REGIMEN FOR MULTIPLE SCLEROSIS AND LYMPHOMA: A RETROSPECTIVE SINGLE CENTER CASE-CONTROL STUDY 126
Autologous hematopoietic stem cell transplantation versus low-dose immunosuppression in secondary-progressive multiple sclerosis 124
Mesenchymal Stem Cells and Autoimmune Diseases: The Case of Multiple Sclerosis 123
CMV and EBV reactivation in autologous haemopoietic stem cell transplantation for severe multiple sclerosis 118
Prevalence of disability improvement as a potential outcome for multiple sclerosis trials 114
Long term follow-up of autologous stem cell transplantation (HSCT) for the treatment of secondary progressive multiple sclerosis: single centre experience 114
Treatment of experimental esophagogastric myotomy with bone marrow mesenchymal stem cells in a rat model. 114
Management of viral reactivation in multiple sclerosis patients after autologous transplantation with BEAM/ATG conditioning regimen 112
Preliminary results of ASTIMS, a prospective randomised Phase II EBMT trial on autologous HSCT in poor prognosis Multiple Sclerosis 111
HSCT for severe multiple sclerosis with BEAM/ATG: impact on female fertility 109
Early measurement of CD34+ cells in peripheral blood after cyclophosphamide and granulocyte colony-stimulating factor treatment predicts later CD34+ mobilisation failure and is a possible criterion for guiding "on demand" use of plerixafor 109
Sustained disease remission in multiple sclerosis after autologous haematopoietic stem cell transplantation. The Italian experience 106
GENE EXPRESSION ANALYSIS OF PBMNC FROM MS PATIENTS UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANTATION (HSCT) 105
intermediate intensity regimen in autologous HSCT for severe Multiple Sclerosis: a a large, single center experience 104
Long-Term Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis 104
Comparing human bone marrow mesenchymal stem cells isolated from MS patients with ND ones: possible impact on MS therapy and immunopathology 103
Hematopoietic Stem Cell Transplantation for the Treatment of Autoimmune Neurological Diseases: An Update 102
Impact of autologous haematopoietic stem cell transplantation on fertility in aggressive multiple sclerosis 98
Safety profile of autologous haematopoietic stem cell transplantation following natalizumab therapy in aggressive forms of multiple sclerosis 97
DIFFERENCES IN MSCS IP-10 PRODUCTION BETWEEN MS PATIENTS AND HEALTHY DONORS 96
Impact of new DMAs on the safety profile of patients undergoing autologous haematopoietic stem cell transplantation for Multiple Sclerosis 95
Purely myeloablative conditioning regimen in aggressive multiple sclerosis: two case reports 95
Intermediate intensity regimen in autologous HSCT for severe multiple sclerosis: a large, single center experience 93
The role of chemotherapy in hematopoietic stem cell transplantation for autoimmune disorders: From lymphoablative to myeloablative conditioning protocols 85
Should autologous hematopoietic stem cell transplantation be offered as a first-line disease modifying therapy to patients with multiple sclerosis? 83
Long term outcomes after autologous hematopoietic stem cell transplantation for treatment of MS 78
Panel Session Report: Multiple Sclerosis 75
Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis and neuromyelitis optica spectrum disorder — recommendations from ECTRIMS and the EBMT 68
Aggressive MS and Autologous HSCT: A review on behalf of the Autoimmune Diseases Working Party of the European Society for Blood and Marrow Transplantation 66
BEAM/ATG or cyclophosphamide/ATG as conditioning regimen in autologous haemopoietic stem cell transplantation for multiple sclerosis: a retrospective analysis of the EBMT autoimmune diseases working party 10
Totale 6.885
Categoria #
all - tutte 20.612
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.612


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021129 0 0 0 0 0 16 15 14 23 36 15 10
2021/2022280 3 32 12 24 17 5 8 32 15 6 42 84
2022/2023899 57 197 61 35 60 142 117 61 92 0 35 42
2023/2024472 10 61 50 31 38 57 22 85 9 29 52 28
2024/20252.708 120 290 171 463 698 393 55 126 114 49 98 131
2025/20261.704 361 437 284 268 341 13 0 0 0 0 0 0
Totale 6.885